Establishing the UK’s first high-energy proton therapy service at the Christie Hospital Manchester and University College London Hospital.

Impact: Health and wellbeing, Economic, Technological

Narrative

Proton-beam therapy offers improved patient-dose deposition over conventional radiotherapy, improving outcomes for patients through reduced side effects and making it particularly suited for paediatric treatments. University of Manchester (UoM) research underpinned the design, procurement plan and ongoing operation of the two bespoke, flexible and future-proof NHS proton-beam therapy treatment centres in Manchester and London, procured for a combined sum in excess of GBP250,000,000.
Commencing treatment in November 2018, the Christie Proton Therapy Centre at Manchester has treated approximately 400 patients, offering an estimated average 11.2 quality-adjusted life-years (QALY) per patient; 1.8 QALYs per patient greater than conventional radiotherapy.
These UK state-of-the-art treatments have reduced the need for the previous provision of 200 annual overseas referrals, at a greatly reduced cost. This saved the NHS at least GBP60,000 per patient; it also opened up treatment to patients from a much wider demographic, including those too ill to travel.
Impact date1 Aug 2013 → 31 Jul 2020
Category of impactHealth and wellbeing, Economic, Technological
Impact levelAdoption

Research Beacons, Institutes and Platforms

  • Cancer
  • Policy@Manchester
  • Dalton Nuclear Institute

Documents & Links

Related content